Pharmacokinetic study of Polydopamine Guttate Pills loaded with active components of Sarcandrae Herba in rats.
10.19540/j.cnki.cjcmm.20220513.502
- Author:
Xi-Tong WANG
1
;
Jia-Yu ZOU
1
;
Yu-Tong WANG
1
;
Rui CHEN
1
;
Heng LIU
1
;
Lin-Wei CHEN
1
;
Yi GU
1
;
De-Xiong DAI
2
;
Xin XU
3
;
Zhi-Peng CHEN
1
Author Information
1. Jiangsu Key Laboratory of Chinese Medicine Processing, Nanjing University of Chinese Medicine Nanjing 210023, China.
2. Zhejiang Weikang Pharmaceutical Co., Ltd. Lishui 323000,China.
3. Productivity Center of Jiangsu Province Nanjing 210042, China.
- Publication Type:Journal Article
- Keywords:
Sarcandrae Herba;
guttate pill;
pharmacokinetics;
polydopamine(PDA)
- MeSH:
Animals;
Chromatography, High Pressure Liquid/methods*;
Drugs, Chinese Herbal/pharmacokinetics*;
Indoles;
Polymers;
Rats;
Rats, Sprague-Dawley;
Reproducibility of Results;
Tandem Mass Spectrometry/methods*
- From:
China Journal of Chinese Materia Medica
2022;47(16):4462-4468
- CountryChina
- Language:Chinese
-
Abstract:
An ultra-high performance liquid chromatography-tandem mass spectrometry(UHPLC-MS/MS) method was established for the determination of active components of Sarcandrae Herba, and applied to the pharmacokinetics study of multiple dosage forms. After SD rats were administered by gavage with three dosage forms [Sarcandrae Herba extract, commercial Sarcandrae Herba Guttate Pills, and polydopamine guttate pills loaded with active components of Sarcandrae Herba(PDA-Sg Guttate Pills)], blood samples were collected from the inner canthus at different time points. After protein precipitation, plasma samples were separated on ACQUITY UPLC C_(18) column(2.1 mm×100 mm, 1.7 μm). The mobile phase consisted of water containing 0.2% formic acid and acetonitrile in gradient elution. The negative ions were measured simultaneously in the multi-reaction monitoring(MRM) mode. The pharmacokinetic parameters were calculated and fitted by DAS 2.0. All four components could be detected in the plasma of rats in each group at each time point except the neochlorogenic acid and cryptochlorogenic acid in the Sarcandrae Herba extract group. The guttate pills group showed a significant increase in drug content at each time point. The exposure of the main components of Sarcandrae Herba in blood was effectively increased by PDA-drug loading effect in PDA-Sg Guttate Pills(The AUC_(0-24 h) of neochlorogenic acid, cryptochlorogenic acid, isaziridin and rosmarinic acid reached 2.45, 32.90, 1.54, 4.81 times that of the commercial guttate pills). This study proves the measurability of the above-mentioned multi-component in vitro-in vivo delivery process. The pharmacokinetic study has shown that PDA-Sg Guttate Pills can effectively delay the elimination time and improve the bioavailability of the four components, which can provide theoretical data for the production of the drug.
